Invesco LLC (Illinois)’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.23M Hold
51,008
0.38% 58
2026
Q1
$1.43M Hold
51,008
0.5% 50
2025
Q4
$1.27M Hold
51,008
0.43% 57
2025
Q3
$1.3M Hold
51,008
0.44% 55
2025
Q2
$1.24M Hold
51,008
0.46% 53
2025
Q1
$1.29M Sell
51,008
-7,762
-13% -$203K 0.53% 50
2024
Q4
$1.56M Sell
58,770
-650
-1% -$17.6K 0.62% 40
2024
Q3
$1.72M Hold
59,420
0.69% 36
2024
Q2
$1.66M Hold
59,420
0.69% 39
2024
Q1
$1.65M Sell
59,420
-6,366
-10% -$177K 0.7% 40
2023
Q4
$1.89M Hold
65,786
0.88% 30
2023
Q3
$2.18M Buy
65,786
+850
+1% +$30.1K 1.1% 23
2023
Q2
$2.38M Buy
+64,936
New +$2.53M 1.17% 19

Other funds holding PFE

Invesco LLC (Illinois)'s PFE Position: Q2 2026 in Review

Invesco LLC (Illinois) held its Pfizer (PFE) position steady in Q2 2026 at 51,008 shares worth $1.23M. The position accounts for 0.38% of the portfolio, ranked #58.

Invesco LLC (Illinois) first reported a position in PFE in Q2 2023 and has held it in 13 quarters since. The position peaked at $2.38M in Q2 2023. 1,338 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Invesco LLC (Illinois) held 51,008 shares of Pfizer worth $1.23M as of Q2 2026.
  • Invesco LLC (Illinois) left its Pfizer share count unchanged in Q2 2026.
  • Pfizer made up 0.38% of Invesco LLC (Illinois)'s portfolio in Q2 2026, its #58 holding.
  • Invesco LLC (Illinois) first reported a position in Pfizer in Q2 2023 and has held it in 13 quarters since.
  • Invesco LLC (Illinois)'s Pfizer position peaked at $2.38M in Q2 2023.
  • 1,338 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Invesco LLC (Illinois)'s 13F filing for Q2 2026, filed 21 Jul 2026.